Denise Beady was 37 years old when she was diagnosed with early-stage breast
cancer in 2017. She sought out care at Dana-Farber, in part because she was so
young at the time of her diagnosis. In 2022, Denise felt another lump under her arm, and after tests and scans, it was revealed that Denise was having a recurrence of her breast cancer and it returned as stage 4

Denise works as a paramedic and dispatcher. When she’s not working, she enjoys
spending time with her husband Robert, and her two boys Tyler, 14, and Ryan, 11. She spends a lot of time driving them to different sports activities. Both of her kids do obstacle training at a gym in Weymouth. Her oldest runs cross country and her younger son plays soccer.

Dr. Burstein is one of the world’s leading experts in the multi-disciplinary and medical management of early- and late-stage breast cancer. Dr. Burstein has led or participated in innumerable clinical trials for breast cancer, including Phase 1, 2 and 3 studies of novel agents, biological treatments, chemotherapy, hormonal therapy, multi-disciplinary care, and quality of life. He writes widely on management of breast cancer, and his publications can be found in the New England Journal of Medicine, the Journal of Clinical Oncology, JAMA, and other leading medical journals.